JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$5.57B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.73B |
| 3 |
AbbVie
ABBV
|
+$1.02B |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$827M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$778M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.43B |
| 2 |
Amazon
AMZN
|
+$1.85B |
| 3 |
Cigna
CI
|
+$1.16B |
| 4 |
Microsoft
MSFT
|
+$1.08B |
| 5 |
Morgan Stanley
MS
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.67% |
| 2 | Technology | 15.47% |
| 3 | Financials | 11.13% |
| 4 | Healthcare | 9.58% |
| 5 | Consumer Discretionary | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CRT
5901
Cross Timbers Royalty Trust
CRT
$69.1M
| $13K | ﹤0.01% |
900
| – | – |
2019 Q1
10 quarters
|
|
5902
CALL
Dana Inc
DAN
$3.12B
| $13K | ﹤0.01% |
+600
| New | +$13.8K |
2021 Q3
0 quarters
|
|
|
FBRX
5903
DELISTED
Forte Biosciences
FBRX
| $13K | ﹤0.01% |
178
+5
| +3% | +$2.77K |
2021 Q2
1 quarter
|
|
5904
CALL
Golar LNG
GLNG
$4.94B
| $13K | ﹤0.01% |
1,000
| – | – |
2019 Q3
8 quarters
|
|
5905
iShares North American Natural Resources ETF
IGE
$794M
| $13K | ﹤0.01% |
456
-2,592
| -85% | -$74.5K |
2021 Q1
2 quarters
|
|
5906
Larimar Therapeutics
LRMR
$280M
| $13K | ﹤0.01% |
1,112
+361
| +48% | +$4.33K |
2020 Q4
3 quarters
|
|
5907
Nuveen ESG Mid-Cap Growth ETF
NUMG
$356M
| $13K | ﹤0.01% |
+235
| New | +$13.2K |
2021 Q3
0 quarters
|
|
5908
Nuveen ESG Mid-Cap Value ETF
NUMV
$440M
| $13K | ﹤0.01% |
+351
| New | +$12.9K |
2021 Q3
0 quarters
|
|
|
MDVL
5909
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $13K | ﹤0.01% |
90
| – | – |
2021 Q2
1 quarter
|
|
|
RVLP
5910
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $13K | ﹤0.01% |
4,253
-33,353
| -89% | -$112K |
2018 Q4
11 quarters
|
|
|
ABB
5911
PUT
DELISTED
ABB Ltd
ABB
| $13K | ﹤0.01% |
+400
| New | +$14.5K |
2021 Q3
0 quarters
|
|
5912
Amplify AI Powered Equity ETF
AIEQ
$115M
| $12K | ﹤0.01% |
300
+200
| +200% | +$8.36K |
2020 Q3
4 quarters
|
|
|
BBU
5913
DELISTED
Brookfield Business Partners
BBU
| $12K | ﹤0.01% |
393
+25
| +7% | +$706 |
2016 Q2
21 quarters
|
|
|
CLSD
5914
DELISTED
Clearside Biomedical
CLSD
| $12K | ﹤0.01% |
133
-367
| -73% | -$32.4K |
2017 Q4
15 quarters
|
|
5915
Capital Southwest
CSWC
$1.51B
| $12K | ﹤0.01% |
+471
| New | +$12.3K |
2021 Q3
0 quarters
|
|
5916
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.81B
| $12K | ﹤0.01% |
408
| – | – |
2018 Q2
13 quarters
|
|
5917
Dave Inc Warrants
DAVEW
$13.8M
| – | – |
0
| – | – |
2021 Q3
0 quarters
|
|
|
DFS
5918
CALL
DELISTED
Discover Financial Services
DFS
| $12K | ﹤0.01% |
100
| – | – |
2020 Q2
5 quarters
|
|
5919
iShares Emerging Markets Dividend ETF
DVYE
$1.21B
| $12K | ﹤0.01% |
300
-6,750
| -96% | -$261K |
2020 Q1
6 quarters
|
|
5920
iShares MSCI Indonesia ETF
EIDO
$414M
| $12K | ﹤0.01% |
558
-141,735
| -100% | -$2.94M |
2014 Q4
27 quarters
|
|
5921
PUT
Fidelity National Information Services
FIS
$17.7B
| $12K | ﹤0.01% |
+100
| New | +$13.4K |
2021 Q3
0 quarters
|
|
5922
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$385M
| $12K | ﹤0.01% |
218
+213
| +4,260% | +$14.5K |
2021 Q1
2 quarters
|
|
|
PHX
5923
DELISTED
PHX Minerals
PHX
| $12K | ﹤0.01% |
3,976
+444
| +13% | +$1.3K |
2017 Q3
16 quarters
|
|
5924
Invesco International Dividend Achievers ETF
PID
$857M
| $12K | ﹤0.01% |
700
| – | – |
2018 Q2
13 quarters
|
|
5925
Direxion Daily Semiconductor Bear 3X ETF
SOXS
$1.85B
| – | – |
0
| – | – |
2021 Q3
0 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2021 Portfolio in Review
As of Q3 2021, JP Morgan Chase held 7,104 positions worth $809B, down 3.5% from $838B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q3 2021 filing shows 647 new, 2,077 increased, 3,085 reduced and 500 closed positions. Its largest new stake was Toast: 2,760,295 shares worth $138M. The largest sale was Apple, an estimated $2.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q3 2021 buy was Toast: 2,760,295 shares worth $138M.
- JP Morgan Chase added most to Vanguard Short-Term Bond ETF in Q3 2021, an estimated $5.57B increase.
- JP Morgan Chase's biggest Q3 2021 reduction was Apple, cutting an estimated $2.43B.
- JP Morgan Chase fully exited Weingarten Realty Investors in Q3 2021, selling an estimated $401M.
- JP Morgan Chase's ten largest holdings make up 16% of its $809B portfolio in Q3 2021.
- JP Morgan Chase opened 647 new positions and closed 500 in Q3 2021.
- JP Morgan Chase's portfolio value fell 3.5% quarter-over-quarter to $809B.
Based on JP Morgan Chase's 13F filing for Q3 2021, filed 12 Nov 2021.